DNA X, Inc.(SONM)— Stock Profile, AI Score & Financials
Technology · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
DNA X, Inc. (SONM) stock profile, AI quality score, and SEC EDGAR financial data, a Technology sector company. 13F Pro's AI-powered ranking engine scores SONM at 26.5/100 on a 32-signal composite quality model, placing it at rank #2,574 of 2,884 stocks — the bottom half of the AI-ranked universe. SONM scores in the top quartile across balance sheet strength (94.5). Areas of concern include earnings quality (1.2) and revenue growth (3.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 33.1/100, reflecting ongoing share issuance or stock-based compensation. Top institutional holders of SONM by reported 13-F value include C2C Wealth Management, BlackRock, CITADEL ADVISORS, based on the most recent SEC filings. SONM trades on the Nasdaq exchange and files with the SEC under CIK 1178697. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SONM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for DNA X, Inc. directly from SEC EDGAR.
AI Quality Score
26.5/100
AI Rank
#2,574
Net Income
$-1.2M
SONM key financials by period
DNA X, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2024
10-K
$58.3M
$-33.6M
-5.3%
FY 2023
10-K
$93.6M
$-90.0K
0.5%
FY 2022
10-K
$69.8M
$-14.1M
-20.5%
FY 2021
10-K/A
$54.6M
$-38.6M
-69.6%
FY 2020
10-K/A
$64.0M
$-29.9M
-45.7%
FY 2019
10-K
$116.3M
$-25.8M
-19.3%
Institutions holding SONM
Institutional investors reporting a position in DNA X, Inc. on SEC Form 13F.
